Biocompatibility & Safety Strategy
Thoughtful biological evaluation support for medical device teams.
INTRO
Building the Right Testing Path Starts With the Right Questions
Biological evaluation should be shaped around the product - not just a checklist.
Biocompatibility and safety planning can quickly become complex. Materials, duration of use, patient contact, existing data, and product risk all influence the path forward.
TEM Biomed helps teams build focused, product-specific strategies before testing begins – supporting clearer study decisions and more meaningful data.
SUPPORT CAN INCLUDE:
- Biological evaluation planning
- ISO 10993 strategy support
- Biocompatibility study planning
- In vivo considerations
- Testing strategy review
- Existing data review
- CRO and vendor coordination
- Report review and scientific interpretation
STRATEGY SECTION
A Risk-Based, Product-Specific Approach
Not every product needs the same testing path.
TEM Biomed works closely with teams to review the product, risk profile, existing data, and development goals before additional testing decisions are made.
The focus is on building a thoughtful strategy that supports the next step with clarity and confidence.